Radiopharmaceuticals Market Size, Share, Growth, and Industry Analysis, By Type (Diagnostic Radioisotopes,Therapeutic Radioisotopes), By Application (Oncology,Cardiology,Other), Regional Insights and Forecast to 2034

Detailed TOC of Radiopharmaceuticals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

1 Market Overview
1.1 Radiopharmaceuticals Product Introduction
1.2 Global Radiopharmaceuticals Market Size Forecast
1.2.1 Global Radiopharmaceuticals Sales Value (2019-2030)
1.2.2 Global Radiopharmaceuticals Sales Volume (2019-2030)
1.2.3 Global Radiopharmaceuticals Sales Price (2019-2030)
1.3 Radiopharmaceuticals Market Trends & Drivers
1.3.1 Radiopharmaceuticals Industry Trends
1.3.2 Radiopharmaceuticals Market Drivers & Opportunity
1.3.3 Radiopharmaceuticals Market Challenges
1.3.4 Radiopharmaceuticals Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Radiopharmaceuticals Players Revenue Ranking (2023)
2.2 Global Radiopharmaceuticals Revenue by Company (2019-2024)
2.3 Global Radiopharmaceuticals Players Sales Volume Ranking (2023)
2.4 Global Radiopharmaceuticals Sales Volume by Company Players (2019-2024)
2.5 Global Radiopharmaceuticals Average Price by Company (2019-2024)
2.6 Key Manufacturers Radiopharmaceuticals Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Radiopharmaceuticals Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Radiopharmaceuticals
2.9 Radiopharmaceuticals Market Competitive Analysis
2.9.1 Radiopharmaceuticals Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceuticals Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diagnostic Radioisotopes
3.1.2 Therapeutic Radioisotopes
3.2 Global Radiopharmaceuticals Sales Value by Type
3.2.1 Global Radiopharmaceuticals Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Radiopharmaceuticals Sales Value, by Type (2019-2030)
3.2.3 Global Radiopharmaceuticals Sales Value, by Type (%) (2019-2030)
3.3 Global Radiopharmaceuticals Sales Volume by Type
3.3.1 Global Radiopharmaceuticals Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Radiopharmaceuticals Sales Volume, by Type (2019-2030)
3.3.3 Global Radiopharmaceuticals Sales Volume, by Type (%) (2019-2030)
3.4 Global Radiopharmaceuticals Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Other
4.2 Global Radiopharmaceuticals Sales Value by Application
4.2.1 Global Radiopharmaceuticals Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Radiopharmaceuticals Sales Value, by Application (2019-2030)
4.2.3 Global Radiopharmaceuticals Sales Value, by Application (%) (2019-2030)
4.3 Global Radiopharmaceuticals Sales Volume by Application
4.3.1 Global Radiopharmaceuticals Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Radiopharmaceuticals Sales Volume, by Application (2019-2030)
4.3.3 Global Radiopharmaceuticals Sales Volume, by Application (%) (2019-2030)
4.4 Global Radiopharmaceuticals Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Radiopharmaceuticals Sales Value by Region
5.1.1 Global Radiopharmaceuticals Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Radiopharmaceuticals Sales Value by Region (2019-2024)
5.1.3 Global Radiopharmaceuticals Sales Value by Region (2025-2030)
5.1.4 Global Radiopharmaceuticals Sales Value by Region (%), (2019-2030)
5.2 Global Radiopharmaceuticals Sales Volume by Region
5.2.1 Global Radiopharmaceuticals Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Radiopharmaceuticals Sales Volume by Region (2019-2024)
5.2.3 Global Radiopharmaceuticals Sales Volume by Region (2025-2030)
5.2.4 Global Radiopharmaceuticals Sales Volume by Region (%), (2019-2030)
5.3 Global Radiopharmaceuticals Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Radiopharmaceuticals Sales Value, 2019-2030
5.4.2 North America Radiopharmaceuticals Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Radiopharmaceuticals Sales Value, 2019-2030
5.5.2 Europe Radiopharmaceuticals Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Radiopharmaceuticals Sales Value, 2019-2030
5.6.2 Asia Pacific Radiopharmaceuticals Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Radiopharmaceuticals Sales Value, 2019-2030
5.7.2 South America Radiopharmaceuticals Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Radiopharmaceuticals Sales Value, 2019-2030
5.8.2 Middle East & Africa Radiopharmaceuticals Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Radiopharmaceuticals Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Radiopharmaceuticals Sales Value
6.2.1 Key Countries/Regions Radiopharmaceuticals Sales Value, 2019-2030
6.2.2 Key Countries/Regions Radiopharmaceuticals Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Radiopharmaceuticals Sales Value, 2019-2030
6.3.2 United States Radiopharmaceuticals Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Radiopharmaceuticals Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Radiopharmaceuticals Sales Value, 2019-2030
6.4.2 Europe Radiopharmaceuticals Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Radiopharmaceuticals Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Radiopharmaceuticals Sales Value, 2019-2030
6.5.2 China Radiopharmaceuticals Sales Value by Type (%), 2023 VS 2030
6.5.3 China Radiopharmaceuticals Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Radiopharmaceuticals Sales Value, 2019-2030
6.6.2 Japan Radiopharmaceuticals Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Radiopharmaceuticals Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Radiopharmaceuticals Sales Value, 2019-2030
6.7.2 South Korea Radiopharmaceuticals Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Radiopharmaceuticals Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Radiopharmaceuticals Sales Value, 2019-2030
6.8.2 Southeast Asia Radiopharmaceuticals Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Radiopharmaceuticals Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Radiopharmaceuticals Sales Value, 2019-2030
6.9.2 India Radiopharmaceuticals Sales Value by Type (%), 2023 VS 2030
6.9.3 India Radiopharmaceuticals Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Company Information
7.1.2 Bracco Imaging Introduction and Business Overview
7.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Bracco Imaging Radiopharmaceuticals Product Offerings
7.1.5 Bracco Imaging Recent Development
7.2 Bayer
7.2.1 Bayer Company Information
7.2.2 Bayer Introduction and Business Overview
7.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bayer Radiopharmaceuticals Product Offerings
7.2.5 Bayer Recent Development
7.3 Mallinckrodt
7.3.1 Mallinckrodt Company Information
7.3.2 Mallinckrodt Introduction and Business Overview
7.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Mallinckrodt Radiopharmaceuticals Product Offerings
7.3.5 Mallinckrodt Recent Development
7.4 Nordion
7.4.1 Nordion Company Information
7.4.2 Nordion Introduction and Business Overview
7.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Nordion Radiopharmaceuticals Product Offerings
7.4.5 Nordion Recent Development
7.5 Triad Isotopes
7.5.1 Triad Isotopes Company Information
7.5.2 Triad Isotopes Introduction and Business Overview
7.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Triad Isotopes Radiopharmaceuticals Product Offerings
7.5.5 Triad Isotopes Recent Development
7.6 Lantheus
7.6.1 Lantheus Company Information
7.6.2 Lantheus Introduction and Business Overview
7.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Lantheus Radiopharmaceuticals Product Offerings
7.6.5 Lantheus Recent Development
7.7 IBA Group
7.7.1 IBA Group Company Information
7.7.2 IBA Group Introduction and Business Overview
7.7.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.7.4 IBA Group Radiopharmaceuticals Product Offerings
7.7.5 IBA Group Recent Development
7.8 GE Healthcare
7.8.1 GE Healthcare Company Information
7.8.2 GE Healthcare Introduction and Business Overview
7.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.8.4 GE Healthcare Radiopharmaceuticals Product Offerings
7.8.5 GE Healthcare Recent Development
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Company Information
7.9.2 China Isotope & Radiation Introduction and Business Overview
7.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.9.4 China Isotope & Radiation Radiopharmaceuticals Product Offerings
7.9.5 China Isotope & Radiation Recent Development
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Company Information
7.10.2 Jubilant Pharma Introduction and Business Overview
7.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Jubilant Pharma Radiopharmaceuticals Product Offerings
7.10.5 Jubilant Pharma Recent Development
7.11 Eli Lilly
7.11.1 Eli Lilly Company Information
7.11.2 Eli Lilly Introduction and Business Overview
7.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Eli Lilly Radiopharmaceuticals Product Offerings
7.11.5 Eli Lilly Recent Development
7.12 Advanced Accelerator Applications
7.12.1 Advanced Accelerator Applications Company Information
7.12.2 Advanced Accelerator Applications Introduction and Business Overview
7.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Offerings
7.12.5 Advanced Accelerator Applications Recent Development
7.13 SIEMENS
7.13.1 SIEMENS Company Information
7.13.2 SIEMENS Introduction and Business Overview
7.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.13.4 SIEMENS Radiopharmaceuticals Product Offerings
7.13.5 SIEMENS Recent Development
7.14 Dongcheng
7.14.1 Dongcheng Company Information
7.14.2 Dongcheng Introduction and Business Overview
7.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Dongcheng Radiopharmaceuticals Product Offerings
7.14.5 Dongcheng Recent Development
7.15 Navidea
7.15.1 Navidea Company Information
7.15.2 Navidea Introduction and Business Overview
7.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Navidea Radiopharmaceuticals Product Offerings
7.15.5 Navidea Recent Development
8 Industry Chain Analysis
8.1 Radiopharmaceuticals Industrial Chain
8.2 Radiopharmaceuticals Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Radiopharmaceuticals Sales Model
8.5.2 Sales Channel
8.5.3 Radiopharmaceuticals Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer